Literature DB >> 7029735

Metabolism and requirements of ascorbic acid in man.

D Hornig.   

Abstract

The metabolism and absorption of ascorbic acid in man are reviewed. The daily requirement of ascorbic acid in male non-smoking volunteers was studied by following the kinetics of a single dose of (1-14C) ascorbic acid under steady-state conditions. A diet low in vitamin C and daily supplements of ascorbic acid (30-180 mg) were given. The time course of elimination of radioactivity from plasma and urinary excretion data were used to calculate kinetic parameters. The overall half-life was calculated as 10 - 20 days and is dependent of plasma ascorbate levels. The body pool approached 20 mg/kg body weight at a plasma ascorbate concentration of 0.9 mg/dl and was maintained by a total turnover of 60 mg/d. The necessary daily intake of ascorbic acid to match this turnover is 70-80 mg, since absorption is incomplete (80-90%). Therefore, to cover at least 95% of the non-smoking male population a daily intake of 100 mg ascorbic acid is required. Similar studies have been carried out in smokers known to have lowered plasma ascorbate levels. Results suggest that the requirement of ascorbic acid is increased in smokers--a daily intake of 140 mg ascorbic acid is thought to be adequate non-smoking male population a daily intake of 100 mg ascorbic acid is required. Similar studies have been carried out in smokers known to have lowered plasma ascorbate levels. Results suggest that the requirement of ascorbic acid is increased in smokers-a daily intake of 140 mg ascorbic acid is thought to be adequate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7029735

Source DB:  PubMed          Journal:  S Afr Med J


  6 in total

1.  Computational models to assign biopharmaceutics drug disposition classification from molecular structure.

Authors:  Akash Khandelwal; Praveen M Bahadduri; Cheng Chang; James E Polli; Peter W Swaan; Sean Ekins
Journal:  Pharm Res       Date:  2007-09-11       Impact factor: 4.200

2.  Ascorbic acid absorption in Crohn's disease. Studies using L-[carboxyl-14C]ascorbic acid.

Authors:  S H Pettit; J L Shaffer; C W Johns; R J Bennett; M H Irving
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

Review 3.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  Vitamin C supplementation is necessary for patients with coronavirus disease: An ultra-high-performance liquid chromatography-tandem mass spectrometry finding.

Authors:  Yaru Xing; Bing Zhao; Lin Yin; Mingquan Guo; Huichun Shi; Zhaoqin Zhu; Lin Zhang; Juan He; Yun Ling; Menglu Gao; Hongzhou Lu; Enqiang Mao; Lijun Zhang
Journal:  J Pharm Biomed Anal       Date:  2021-01-27       Impact factor: 3.935

5.  The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: Low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma.

Authors:  Roy Moncayo; Alexander Kroiss; Manfred Oberwinkler; Fatih Karakolcu; Matthias Starzinger; Klaus Kapelari; Heribert Talasz; Helga Moncayo
Journal:  BMC Endocr Disord       Date:  2008-01-25       Impact factor: 2.763

Review 6.  Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence.

Authors:  Margreet C M Vissers; Andrew B Das
Journal:  Front Physiol       Date:  2018-07-03       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.